EX-2.1
from 10-Q
73 pages
Stock Purchase Agreement by and Among Alnylam Pharmaceuticals, Inc., Sirna Therapeutics, Inc., Merck Sharp & Dohme Corp., and Solely for Purposes of Sections 3.19, 5.2, 5.6, 9.2(b)(ii), 9.2(d) and Article XI Herein, Merck & Co., Inc., Dated: January 10, 2014
12/34/56
